Position in NVCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,271,984
+$7,143,027 QoQ
Shares Held
479,999
+3957.1% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 217 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Derivatives in NVCR
reported options exposure · as of Sep 30, 2023CallValue
$1,049,750
CallShares
65,000
PutValue
$1,348,525
PutShares
83,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $729,959,673 across 38 Medical Devices names. NVCR ranks #15 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
1,090,163 | $344,218,967 | |
| 2 | MDT |
Medtronic plc
|
986,367 | $77,163,489 | |
| 3 | GKOS |
GLAUKOS Corp
|
491,636 | $68,711,047 | |
| 4 | ABT |
Abbott Laboratories
|
740,808 | $67,220,917 | |
| 5 | EW |
Edwards Lifesciences Corp
|
456,202 | $41,268,032 | |
| 6 | 739,829 | $18,406,945 | |||
| 7 | BBNX |
Beta Bionics, Inc.
|
855,682 | $13,408,536 | |
| 8 | AXGN |
Axogen, Inc.
|
253,498 | $11,709,072 |
All Filings in NVCR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,271,984 | 479,999 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $128,957 | 11,831 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $405,213 | 31,339 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $40,407,352 | 2,270,076 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $29,138,390 | 1,635,151 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,852,117 | 1,068,863 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,116,289 | 839,174 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,192,315 | 594,998 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,678,370 | 427,279 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $4,729,867 | 316,803 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,348,525 | 83,500 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $17,920,282 | 1,109,615 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $1,049,750 | 65,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $35,652,899 | 859,106 | Shares | Other | 2023-08-14 | |
| 2023-06-30 | $16,185,000 | 390,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $2,602,050 | 62,700 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $3,909,100 | 65,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $21,531,863 | 358,029 | Shares | Other | 2023-05-15 | |
| 2022-06-30 | $1,654,100 | 23,800 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $1,971,830 | 23,800 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $3,114,580 | 37,593 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,703,527 | 75,966 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,086,421 | 9,352 | Shares | Sole | 2021-12-01 | |
| 2020-09-30 | $8,970,250 | 80,588 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $21,410,561 | 361,055 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||